NuVision – a Nottingham-based company with a product that speeds up healing of eye conditions – has raised a further £1.1m investment. The funding has
Two consultant ophthalmic surgeons will lead the teaching day on the application of dried amniotic membrane in a range of ophthalmic presentations The session will
Webinar round-up: Five clinicians from four NHS centres present on their case report applications of amniotic membrane in different ophthalmic conditions in a webinar sponsored
Clinicians from four NHS centres are collaborating to present their use of Omnigen, amniotic membrane in the treatment of ocular conditions. On Tuesday 4th October 2022
NuVision Biotherapies, a tissue-based technology company delivering ophthalmic and wound care solutions in the primary care and surgical setting, join the conference to increase their
Employer profile NuVision (www.nu-vision.co.uk) is a leading UK wound care company, committed to developing and commercialising innovative high quality human tissue products. Our launch focus
Employer profile NuVision (www.nu-vision.co.uk) is a leading UK wound care company, committed to developing and commercialising innovative high quality human tissue products. Our launch focus
NuVision Biotherapies is joining the Department of International Trade (DIT) at Medica World Trade Fair this November to expand their international profile Medica is the
Webinar Round-Up: UK ophthalmologists present on their innovations of amniotic membrane application in the management of ocular surface disease sponsored by NuVision Biotherapies Ltd. The
Additional options for the application of amniotic membrane in-clinic NuVision® Biotherapies, a company based in MediCity, Nottingham, manufactures a human amniotic membrane product using the
